DESIRE: Feasibility Testing a shareD dEciSIon Making Intervention for People With Kidney failuRE, Their Relatives, and the Health Professionals in Kidney Services: a Pilot Randomized Controlled Trial Study Protocol

Sponsor
University of Aarhus (Other)
Overall Status
Recruiting
CT.gov ID
NCT05842772
Collaborator
(none)
32
1
2
5.4
5.9

Study Details

Study Description

Brief Summary

The aim of this research is to test the acceptability and feasibility of a shared decision making intervention and a patient decision aid to support patients with kidney failure, relatives, and health professionals in planning and deciding about end-of-life care together.

Condition or Disease Intervention/Treatment Phase
  • Other: Shared decision making intervention for patients with kidney failure when planning end-of-life care
N/A

Detailed Description

The objectives of this study is to pilot test an intervention aiming to accomplish shared decision making when deciding about end-of-life care preferences in people with kidney failure. The intervention consists of shared decision making consultations for adults with kidney failure their relatives and contact health professionals regarding end-of-life care planning supported by a patient decision aid. We will evaluate how adults, relatives and, health professionals implements the intervention and if the intervention is acceptable to the different stakeholders. The research question will investigate if the adults, relatives, and health professionals are experiencing the intervention as shared decision making and if they feel involved in the decision making process.

The DESIRE trial is designed as a pragmatic, pilot, randomized, controlled, non-blinded multicenter superiority trial with two parallel groups will test the acceptability and feasibility of the intervention on patients, relatives, and health professionals. Randomization will be performed as block randomization with a 1:1 allocation.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
32 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The DESIRE trial is designed as a pragmatic, pilot, randomized, controlled, non-blinded multicenter superiority trial with two parallel groups will test the acceptability and feasibility of the intervention on patients, relatives, and health professionals.The DESIRE trial is designed as a pragmatic, pilot, randomized, controlled, non-blinded multicenter superiority trial with two parallel groups will test the acceptability and feasibility of the intervention on patients, relatives, and health professionals.
Masking:
Double (Investigator, Outcomes Assessor)
Masking Description:
The researcher who will conduct the data analyses will type the answers into REDCap and will be blinded to the identity of the participants only knowing them by their unique number.
Primary Purpose:
Supportive Care
Official Title:
Feasibility Testing a shareD dEciSIon Making Intervention for People With Kidney failuRE (DESIRE), Their Relatives, and the Health Professionals in Kidney Services: a Pilot Randomized Controlled Trial Study Protocol
Actual Study Start Date :
Mar 20, 2023
Anticipated Primary Completion Date :
Sep 1, 2023
Anticipated Study Completion Date :
Sep 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention group

The DESIRE intervention which includes training of health professionals, a conversation with patients and their relatives, and a patient decision aid.

Other: Shared decision making intervention for patients with kidney failure when planning end-of-life care
Testing a shared decision making intervention and a patient decision aid for patients with kidney failure, their relatives, and the health professionals.

Active Comparator: Control group

Usual care

Other: Shared decision making intervention for patients with kidney failure when planning end-of-life care
Testing a shared decision making intervention and a patient decision aid for patients with kidney failure, their relatives, and the health professionals.

Outcome Measures

Primary Outcome Measures

  1. change in the patient's palliative care needs [Through study completion, an average of 6 months]

    The primary outcome will be the change in the adults' palliative needs, as measured using the Integrated Palliative Outcome Score (IPOS)-Renal patient version questionnaire

Secondary Outcome Measures

  1. Participants and relatives' experiences of shared decision making and health professionals' conduction of shared decision making are secondary outcomes. [Through study completion, an average of 6 months]

    Participants and relatives' experiences of shared decision making, as measured using the Patient Experience of Shared Decision Making (SHARED) tool and healthprofessionals' conduction of shared decision making, as measured using the Decision Support Analysis Tool (DSAT-10) are secondary outcomes.

Eligibility Criteria

Criteria

Ages Eligible for Study:
75 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adults with kidney failure on haemodialysis, peritoneal dialysis, or on conservative kidney management and their relatives will be considered for participation. Inclusion criteria will be adults ≥75 years of age, with an estimated glomerular filtration rate <15, and not suited for a kidney transplant.
Exclusion Criteria:
  • Adults who are cognitively unable to participate will be excluded from the research.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Aarhus University Hospital Aarhus Denmark 8200

Sponsors and Collaborators

  • University of Aarhus

Investigators

  • Principal Investigator: Louise Engelbrecht Buur, University of Aarhus

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Aarhus
ClinicalTrials.gov Identifier:
NCT05842772
Other Study ID Numbers:
  • PilotRCT_LEB
First Posted:
May 6, 2023
Last Update Posted:
May 6, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Aarhus
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 6, 2023